Global News

The informed consent process

Monday, December 21, 2015

The Pulse on Study Conduct by Elizabeth Weeks-Rowe

To provide an informed consent process that’s transparent and equitable is the most sacrosanct assurance of safety we can provide research patients.

[Read More]

Tetragenetics launches mAbs partnership program

Friday, December 18, 2015

Tetragenetics, an emerging biotechnology company engaged in the expression of ion channel drug targets, has announced a new partnership program for the discovery and development of therapeutic monoclonal antibodies (mAbs) directed against well-known ion channel drug targets implicated in a wide range of disease states—such as pain and autoimmune disorders.

[Read More]

AMRI acquires Whitehouse Laboratories

Thursday, December 17, 2015

Global CRO Albany Molecular Research Inc. (AMRI) has acquired all the outstanding equity interests of Whitehouse Laboratories, a provider of testing services that includes chemical and material analysis, method development and validation, and quality-control verification services to the pharmaceutical, medical device and personal care industries. Total consideration is $54 million in cash, and an additional $2 million in shares of AMRI common stock contingent upon Whitehouse Labs achieving certain 2015 targets.

[Read More]